BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22777530)

  • 1. Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability.
    Rustamov O; Smith A; Roberts SA; Yates AP; Fitzgerald C; Krishnan M; Nardo LG; Pemberton PW
    Hum Reprod; 2012 Oct; 27(10):3085-91. PubMed ID: 22777530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-mixing serum samples with assay buffer is a prerequisite for reproducible anti-Mullerian hormone measurement using the Beckman Coulter Gen II assay.
    Han X; McShane M; Sahertian R; White C; Ledger W
    Hum Reprod; 2014 May; 29(5):1042-8. PubMed ID: 24626805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-centre evaluation of two new anti-Mullerian hormone assays and comparison with the current clinical standard assay.
    Welsh P; Smith K; Nelson SM
    Hum Reprod; 2014 May; 29(5):1035-41. PubMed ID: 24578473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentre evaluation of the new Beckman Coulter anti-Mullerian hormone immunoassay (AMH Gen II).
    Wallace AM; Faye SA; Fleming R; Nelson SM
    Ann Clin Biochem; 2011 Jul; 48(Pt 4):370-3. PubMed ID: 21628625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of three new commercial immunoassays for anti-Müllerian hormone measurement.
    Li HW; Wong BP; Ip WK; Yeung WS; Ho PC; Ng EH
    Hum Reprod; 2016 Dec; 31(12):2796-2802. PubMed ID: 27702835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the Beckman-Coulter second-generation enzyme-linked immunosorbent assay protocol improves the reliability of serum antimüllerian hormone measurement.
    Craciunas L; Roberts SA; Yates AP; Smith A; Fitzgerald C; Pemberton PW
    Fertil Steril; 2015 Feb; 103(2):554-59.e1. PubMed ID: 25487749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the two new fully automated anti-Müllerian hormone immunoassays compared with the clinical standard assay.
    van Helden J; Weiskirchen R
    Hum Reprod; 2015 Aug; 30(8):1918-26. PubMed ID: 26093541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reference range for the antimüllerian hormone Generation II assay: a population study of 10,984 women, with comparison to the established Diagnostics Systems Laboratory nomogram.
    Nelson SM; Iliodromiti S; Fleming R; Anderson R; McConnachie A; Messow CM
    Fertil Steril; 2014 Feb; 101(2):523-9. PubMed ID: 24220704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A; Sauter L; Edimiris P; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
    Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-equivalence of anti-Müllerian hormone automated assays-clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing.
    Iliodromiti S; Salje B; Dewailly D; Fairburn C; Fanchin R; Fleming R; Li HWR; Lukaszuk K; Ng EHY; Pigny P; Tadros T; van Helden J; Weiskirchen R; Nelson SM
    Hum Reprod; 2017 Aug; 32(8):1710-1715. PubMed ID: 28854583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation may modify ovarian reserve in female childhood cancer survivors.
    van Dorp W; van den Heuvel-Eibrink MM; Stolk L; Pieters R; Uitterlinden AG; Visser JA; Laven JS
    Hum Reprod; 2013 Apr; 28(4):1069-76. PubMed ID: 23360674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In women with endometriosis anti-Müllerian hormone levels are decreased only in those with previous endometrioma surgery.
    Streuli I; de Ziegler D; Gayet V; Santulli P; Bijaoui G; de Mouzon J; Chapron C
    Hum Reprod; 2012 Nov; 27(11):3294-303. PubMed ID: 22821432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Mullerian hormone is a more accurate predictor of individual time to menopause than mother's age at menopause.
    Dólleman M; Depmann M; Eijkemans MJ; Heimensem J; Broer SL; van der Stroom EM; Laven JS; Van Rooij IA; Scheffer GJ; Peeters PH; van der Schouw YT; Lambalk CB; Broekmans FJ
    Hum Reprod; 2014 Mar; 29(3):584-91. PubMed ID: 24435779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve.
    Uncu G; Kasapoglu I; Ozerkan K; Seyhan A; Oral Yilmaztepe A; Ata B
    Hum Reprod; 2013 Aug; 28(8):2140-5. PubMed ID: 23624580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical uses of anti-Müllerian hormone assays: pitfalls and promises.
    Streuli I; Fraisse T; Chapron C; Bijaoui G; Bischof P; de Ziegler D
    Fertil Steril; 2009 Jan; 91(1):226-30. PubMed ID: 18249391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of serum anti-Müllerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART).
    Fréour T; Mirallié S; Bach-Ngohou K; Denis M; Barrière P; Masson D
    Clin Chim Acta; 2007 Jan; 375(1-2):162-4. PubMed ID: 16860302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between anti-Müllerian hormone and antral follicle count across the menstrual cycle using the Beckman Coulter Access assay in comparison with Gen II manual assay.
    Schiffner J; Roos J; Broomhead D; Helden JV; Godehardt E; Fehr D; Freundl G; Johnson S; Gnoth C
    Clin Chem Lab Med; 2017 Jun; 55(7):1025-1033. PubMed ID: 27987358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a second generation anti-Müllerian hormone (AMH) ELISA.
    Kumar A; Kalra B; Patel A; McDavid L; Roudebush WE
    J Immunol Methods; 2010 Oct; 362(1-2):51-9. PubMed ID: 20801125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.